Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
iCAD Inc (ICAD)
NASDAQ:ICAD
iCAD (ICAD) Stock Price & Analysis
375 Followers
ICAD Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.05 - $3.97
Previous Close$1.47
Volume62.83K
Average Volume (3M)191.68K
Market Cap
$38.76M
Enterprise Value$17.55M
Total Cash (Recent Filing)$21.67M
Total Debt (Recent Filing)$461.00K
Price to Earnings (P/E)-6.7
Beta0.73
Next Earnings
May 15, 2024EPS Estimate
-$0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding26,540,030
10 Day Avg. Volume99,741
30 Day Avg. Volume191,681
Standard Deviation0.23
R-Squared0.10
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.67
Price to Sales (P/S)24.35
Price to Cash Flow (P/CF)-6.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.20
Enterprise Value/Gross Profit1.19
Enterprise Value/Ebitda-2.67
Forecast
1Y Price Target
$3.00Price Target Upside104.08% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
iCAD News
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthICAD ended Q3 with ~$19M in cash and cash equivalents and no debt.
Financial PerformanceSubscription annual recurring revenue had grown to $1.4M at the end of the quarter.
Operational EfficiencyICAD has a low cash burn and its Detection business enjoys strong gross margins in the mid-80s.
Bears Say
Business DivestitureThe divestiture of the Xoft business could indicate a strategic shift for ICAD, potentially disrupting current revenue streams.
Market ConsensusWith ICAD's reported Q3 revenue missing the consensus estimate, investor confidence may be shaken, impacting stock performance.
Revenue PerformanceICAD's Q3 revenue preannouncement fell short of market expectations, signaling potential underlying business challenges.
---
Ownership Overview
46.40%
Insiders
11.99% Mutual Funds
6.60% Other Institutional Investors
35.01% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ICAD FAQ
What was iCAD Inc’s price range in the past 12 months?
iCAD Inc lowest stock price was $1.05 and its highest was $3.97 in the past 12 months.
What is iCAD Inc’s market cap?
Currently, no data Available
When is iCAD Inc’s upcoming earnings report date?
iCAD Inc’s upcoming earnings report date is May 15, 2024 which is in 10 days.
How were iCAD Inc’s earnings last quarter?
iCAD Inc released its earnings results on Mar 12, 2024. The company reported -$0.02 earnings per share for the quarter, beating the consensus estimate of -$0.055 by $0.035.
Is iCAD Inc overvalued?
According to Wall Street analysts iCAD Inc’s price is currently Undervalued.
Does iCAD Inc pay dividends?
iCAD Inc does not currently pay dividends.
What is iCAD Inc’s EPS estimate?
iCAD Inc’s EPS estimate is -$0.06.
How many shares outstanding does iCAD Inc have?
iCAD Inc has 26,367,775 shares outstanding.
What happened to iCAD Inc’s price movement after its last earnings report?
iCAD Inc reported an EPS of -$0.02 in its last earnings report, beating expectations of -$0.055. Following the earnings report the stock price went up 4.046%.
Which hedge fund is a major shareholder of iCAD Inc?
Among the largest hedge funds holding iCAD Inc’s share is First Eagle Investment Management LLC. It holds iCAD Inc’s shares valued at 1M.
---
iCAD Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$3.00 (104.08% Upside)
$3.00 (104.08% Upside)
Blogger Sentiment
Bullish
ICAD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 18.7K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 5.1%
Last 30 Days ▼ 5.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.52%
12-Months-Change
Fundamentals
Return on Equity
-20.81%
Trailing 12-Months
Asset Growth
-19.90%
Trailing 12-Months
Company Description
iCAD Inc
iCAD, Inc. engages in the provision of advanced image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer. It operates through the Cancer Detection and Cancer Therapy business segments. The Cancer Detection segment includes image analysis and clinical decision support solutions for mammography, breast tomosynthesis, and computed tomography imaging. The Cancer Therapy segment offers an isotope-free cancer treatment platform technology. The company was founded in 1984 and is headquartered in Nashua, NH.
---
ICAD Earnings Call
Q4 2024
0:00 / 0:00
---
ICAD Stock 12 Months Forecast
Average Price Target
$3.00
▲(104.08% Upside)
Technical Analysis
Best Analysts Covering ICAD
1 Year
1 Year Success Rate
4/20 ratings generated profit
1 Year Average Return
-42.03%
reiterated a buy rating 2 months ago
Copying Marie Thibault's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -42.03% per trade.
---